Rating History for Esperion Therapeutics (ESPR) by Piper Sandler

More Stocks Rated by Piper Sandler | Latest Ratings for ESPR
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/25/2025 David Amsellem New Coverage Overweight
(N/A)		 9.00
(N/A)		 3.08
(2.73)		 -11.36% Details